Liposome immune assay (LIA). Use of membrane antigens inserted into labeled lipid vesicles as targets in immune assays.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 7014722)

Published in J Immunol Methods on January 01, 1981

Authors

B Axelsson, H Eriksson, C Borrebaeck, B Mattiasson, H O Sjögren

Articles by these authors

PROTEGE-II: computer support for development of intelligent systems from libraries of components. Medinfo (1995) 5.71

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A (1971) 5.38

The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes (1985) 4.23

Ontology-based configuration of problem-solving methods and generation of knowledge-acquisition tools: application of PROTEGE-II to protocol-based decision support. Artif Intell Med (1995) 3.99

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int J Cancer (1971) 3.06

Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int J Cancer (1971) 2.88

Palliative chemotherapy during the last month of life. Ann Oncol (2011) 2.32

Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines. J Immunol (1989) 2.32

Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol (1988) 2.28

Pre-operative fasting guidelines: an update. Acta Anaesthesiol Scand (2005) 1.94

'Smart' polymers and what they could do in biotechnology and medicine. Trends Biotechnol (1999) 1.91

Transplantation methods as a tool for detection of tumor-specific antigens. Prog Exp Tumor Res (1965) 1.85

Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med (2000) 1.81

Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913". Arch Intern Med (1999) 1.76

Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes. Int J Cancer (1972) 1.76

Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost (2007) 1.74

Deep vein thrombosis and pulmonary embolism in the general population. 'The Study of Men Born in 1913'. Arch Intern Med (1997) 1.62

Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia (1988) 1.53

Matrix-bound enzymes. II. Studies on a matrix-bound two-enzyme-system. Acta Chem Scand (1970) 1.52

Production of TNF-alpha and TNF-beta by staphylococcal enterotoxin A activated human T cells. J Immunol (1990) 1.51

Secular changes in cardiovascular risk factors and attack rate of myocardial infarction among men aged 50 in Gothenburg, Sweden. Accurate prediction using risk models. J Intern Med (2008) 1.49

Optimal risk factors in the population: prognosis, prevalence, and secular trends; data from Göteborg population studies. Eur Heart J (2001) 1.49

Is hypertension changing? Blood pressure development in cohorts of 50-year-old men between 1963 and 1993. Blood Press (1996) 1.48

Heart failure in the general population of men--morbidity, risk factors and prognosis. J Intern Med (2001) 1.46

Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men. Br J Dermatol (2015) 1.43

Can laboratory testing improve screening strategies for deep vein thrombosis at an emergency unit? J Intern Med (1994) 1.41

Kinetics of IL-2 and interferon-gamma production, expression of IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A. Cell Immunol (1985) 1.41

Factors associated with reaching 90 years of age: a study of men born in 1913 in Gothenburg, Sweden. J Intern Med (2010) 1.38

Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Int J Cancer (2000) 1.36

Two subsets of human CD4+ T helper cells differing in kinetics and capacities to produce interleukin 2 and interferon-gamma can be defined by the Leu-18 and UCHL1 monoclonal antibodies. Eur J Immunol (1988) 1.35

Studies on a matrix-bound three-enzyme system. Biochim Biophys Acta (1971) 1.32

Carbohydrate binding activity of a lectin-like glycoprotein from stems and leaves of Dolichos biflorus. Biochem Biophys Res Commun (1980) 1.30

Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma. Int J Cancer (1973) 1.30

A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells. J Immunol (1991) 1.29

Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27

Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity. Int J Cancer (1971) 1.27

CHD in Sweden: mortality, incidence and risk factors over 20 years in Gothenburg. Int J Epidemiol (1989) 1.26

Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells. J Exp Med (2000) 1.24

Cross-reacting tumor-associated antigen (s) among chemically induced rat colon carcinomas. Cancer Res (1974) 1.24

Demonstration of H-2 isoantigens and polyoma specific tumor antigens by measuring colony formation in vitro. Exp Cell Res (1965) 1.23

PROTEGE-II: a suite of tools for development of intelligent systems from reusable components. Proc Annu Symp Comput Appl Med Care (1994) 1.23

Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden. BJU Int (2000) 1.21

Subtraction of Compton-scattered photons in single-photon emission computerized tomography. J Nucl Med (1984) 1.19

Bundle-branch block in a general male population: the study of men born 1913. Circulation (1998) 1.18

An immobilized three-enzyme system: a model for microenvironmental compartmentation in mitochondria. Proc Natl Acad Sci U S A (1973) 1.18

Stimulation of human naive and memory T helper cells with bacterial superantigen. Naive CD4+45RA+ T cells require a costimulatory signal mediated through the LFA-1/ICAM-1 pathway. J Immunol (1992) 1.17

Medical chemistry: evaluation of active and problem-oriented teaching methods. Med Educ (1985) 1.15

B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia. Clin Exp Immunol (1978) 1.14

Characterization of individual tumor necrosis factor alpha-and beta-producing cells after polyclonal T cell activation. J Immunol Methods (1989) 1.14

Induction of CD43 expression during activation and terminal differentiation of human B cells. Scand J Immunol (1988) 1.13

The microbe thermistor. Nature (1977) 1.12

Renal damage after prolonged exposure to cadmium. An experimental study. Arch Environ Health (1966) 1.12

Improving the detection and diagnosis of congestive heart failure. Eur Heart J (1989) 1.11

Helix pomatia lectin, an inducer of Drosophila immune response, binds to hemomucin, a novel surface mucin. J Biol Chem (1996) 1.11

Cloning and functional characterization of a subunit of the transporter associated with antigen processing. Proc Natl Acad Sci U S A (1997) 1.09

Body temperature in general population samples. The study of men born in 1913 and 1923. Acta Med Scand (1985) 1.09

Sequential studies of serum blocking activity in rats bearing chemically induced primary bowel tumors. J Natl Cancer Inst (1975) 1.08

Estrogen receptors alpha and beta in the female reproductive tract of the rat during the estrous cycle. Biol Reprod (2000) 1.08

Fasting blood glucose and risk of coronary heart disease, stroke, and all-cause mortality: a 17-year follow-up study of men born in 1913. Diabet Med (1986) 1.07

T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. Crit Rev Immunol (1995) 1.07

Purification and characterization of cellulases produced by two Bacillus strains. J Biotechnol (2000) 1.07

A comparative study of estrogen receptors alpha and beta in the rat uterus. Biol Reprod (1999) 1.06

Effects of BCG on various facets of the immune response against polyoma tumors in rats. Int J Cancer (1973) 1.06

Induction of interleukin-1 in human monocytes by the superantigen staphylococcal enterotoxin A requires the participation of T cells. Cell Immunol (1991) 1.05

Induction of polyoma specific transplantation antigenicity in Moloney leukemia cells. Exp Cell Res (1965) 1.04

A general, extracorporeal immunoadsorption method to increase the tumor-to-normal tissue ratio in radioimmunoimaging and radioimmunotherapy. J Nucl Med (1993) 1.04

Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligands. Int Immunopharmacol (2001) 1.04

Obesity and trends in cardiovascular risk factors over 40 years in Swedish men aged 50. J Intern Med (2009) 1.02

Detection of heavy metal ions at femtomolar levels using protein-based biosensors. Anal Chem (1998) 1.02

Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis. J Intern Med (2008) 1.02

The large sialoglycoprotein of human lymphocytes. II. Biochemical features. Eur J Immunol (1985) 1.02

Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas. Cell Immunol (1970) 1.02

The Y chromosome: a graveyard for endogenous retroviruses. Gene (1995) 1.02

The poultry red mite, Dermanyssus gallinae, a potential vector of Erysipelothrix rhusiopathiae causing erysipelas in hens. Med Vet Entomol (2003) 1.01

A new approach to determining cholinesterase activities in samples of whole blood. Clin Chim Acta (1978) 1.00

The cDNA sequence of a neutral horseradish peroxidase. Biochim Biophys Acta (1991) 1.00

Utilization of agricultural residues for poly(3-hydroxybutyrate) production by Halomonas boliviensis LC1. J Appl Microbiol (2007) 0.99

Fusion of a signal sequence to the interleukin-1 beta gene directs the protein from cytoplasmic accumulation to extracellular release. Cell Immunol (1996) 0.99

Counteractions of the blocking of cell-mediated tumor immunity by inoculation of unblocking sera and splenectomy: immunotherapeutic effects on primary polyoma tumors in rats. Int J Cancer (1972) 0.99

Effect of ethynylestradiol on biliary excretion of bile acids, phosphatidylcolines, and cholesterol in the bile fistula rat. J Lipid Res (1977) 0.99

Phenotypical and functional differentiation of CD4+ CD45RA+ human T cells following polyclonal activation. Scand J Immunol (1990) 0.98

Specific transplantation antigens of mouse sarcomas induced by adenovirus type 12. J Exp Med (1967) 0.98

Formation of pinopodes in human endometrium is associated with the concentrations of progesterone and progesterone receptors. Fertil Steril (2001) 0.98

"Unblocking" serum activity in vitro in the polyoma system may correlate with antitumour effects of antiserum in vivo. Nat New Biol (1971) 0.98

Hyperinsulinaemia is not a major coronary risk factor in elderly men. The study of men born in 1913. Diabetologia (1992) 0.97

Maximizing the expression of a recombinant gene in Escherichia coli by manipulation of induction time using lactose as inducer. Appl Microbiol Biotechnol (1992) 0.97

Assay procedures for immobilized enzymes. Methods Enzymol (1976) 0.96

Expression of CD40 and CD43 during activation of human B lymphocytes. Scand J Immunol (1991) 0.95

Induction of mammary fibroadenomas in rats by adenovirus type 9. Int J Cancer (1974) 0.95

Newly discovered anti-inflammatory properties of the benzamides and nicotinamides. Mol Cell Biochem (1999) 0.95

Monoclonal antibodies produced by immunization with neoglycoproteins containing Gal alpha 1-4Gal beta 1-4Glc beta-O and Gal alpha 1-4Gal beta 1-4GlcNAc beta-O residues: useful immunochemical and cytochemical reagents for blood group P antigens and a differentiation marker in Burkitt lymphoma and other B-cell malignancies. Int J Cancer (1988) 0.95

The large sialoglycoprotein of human lymphocytes. I. Distribution on T and B lineage cells as revealed by a monospecific chicken antibody. Eur J Immunol (1985) 0.95

Histamine inhibits interleukin 1 production by lipopolysaccharide-stimulated human peripheral blood monocytes. Scand J Immunol (1988) 0.95

Musculo-skeletal symptoms as related to working conditions among Swedish professional fisherman. Appl Ergon (1988) 0.95

Heterogeneity of estrogen binding sites in the cytosol of the rat uterus. J Biol Chem (1978) 0.94

Use of a monoclonal rat anti-mouse Ig light chain (RAMOL-1) antibody reduces background binding in immunohistochemical and fluorescent antibody analysis. J Histochem Cytochem (1989) 0.94

Helix pomatia A hemagglutinin: selectivity of binding to lymphocyte surface glycoproteins on T cells and certain B cells. Eur J Immunol (1978) 0.94